Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intranasal hormone replacement therapy.

Saranya Wattanakumtornkul1, Anil B Pinto, Daniel B Williams

  • 1Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO, USA.

Menopause (New York, N.Y.)
|January 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of estetrol/drospirenone versus ethinyl estradiol/drospirenone on glucose tolerance in women with polycystic ovary syndrome: A randomised controlled trial.

Diabetes, obesity & metabolism·2025
Same author

Brief Report: Undetectable HIV-1 Viral Load Among Virally Suppressed People Living With HIV: Implications for Undetectable Equals Untransmittable (U=U) in Resource-Limited Settings Using Dried Spot Testing.

Journal of acquired immune deficiency syndromes (1999)·2025
Same author

Etiologies and clinical characteristics of primary amenorrhea: A study from a quaternary care hospital in southern Thailand.

The journal of obstetrics and gynaecology research·2025
Same author

Aetiology and Clinical Characteristics of Primary Amenorrhoea with Hypothalamic or Pituitary Disorders at a Quaternary Hospital.

Journal of obstetrics and gynaecology of India·2025
Same author

Causes and clinical characteristics of women with primary amenorrhea and ovarian or gonadal disorders at a quaternary hospital.

The journal of obstetrics and gynaecology research·2024
Same author

Effect of radiation on serum anti-Müllerian hormone during hysterosalpingography in female infertility.

Reproductive biomedicine online·2024
Same journal

Combined adductor pollicis muscle thickness and handgrip strength as predictive indicators for risk stratification of low muscle mass and low bone mass in adult women.

Menopause (New York, N.Y.)·2026
Same journal

Novel and traditional anthropometric measures of obesity association with dynapenia in postmenopausal women.

Menopause (New York, N.Y.)·2026
Same journal

Regulatory awareness, counseling priorities, and treatment choices in menopausal hormone therapy: a cross-sectional survey of obstetricians and gynecologists.

Menopause (New York, N.Y.)·2026
Same journal

Menopause Step-by-Step: must-know studies.

Menopause (New York, N.Y.)·2026
Same journal

Processed foods in the context of a vegan diet, and changes in body weight and severe hot flashes in postmenopausal women: a secondary analysis of a randomized clinical trial.

Menopause (New York, N.Y.)·2026
Same journal

Female and male factors associated with female sexual function in couples aged 50-70 years: a cross-sectional study.

Menopause (New York, N.Y.)·2026
See all related articles

Intranasal hormone replacement therapy offers an effective and convenient option for postmenopausal women. This innovative delivery method improves patient satisfaction and compliance with hormone therapy.

Area of Science:

  • Endocrinology
  • Pharmacology
  • Women's Health

Background:

  • Optimal hormone replacement therapy (HRT) delivery aims for efficacy, ease of use, and minimal side effects.
  • Patient compliance and satisfaction are key factors in successful HRT.
  • Current HRT delivery routes may have limitations in efficacy or patient acceptance.

Purpose of the Study:

  • To evaluate the intranasal route for administering menopausal hormones.
  • To assess the safety, efficacy, and acceptability of intranasal HRT in postmenopausal women.
  • To explore intranasal delivery as an alternative for sex steroid administration.

Main Methods:

  • Evaluation of the intranasal route for hormone delivery.
  • Assessment of menopausal hormone administration via nasal spray.

Related Experiment Videos

  • Review of early studies on intranasal estradiol and progesterone.

    • Main Results:

    • The intranasal route appears to meet desirable criteria for HRT, including efficacy and ease of administration.
    • This method avoids hepatic first-pass elimination, beneficial for drugs with poor oral absorption.
    • Early studies indicate intranasal HRT is safe, effective, and acceptable to postmenopausal women.
    • Nasal administration of estradiol and progesterone is a promising option for non-hysterectomized women.

    Conclusions:

    • The intranasal route is an innovative and viable option for delivering natural sex steroids in postmenopausal women.
    • Intranasal HRT demonstrates potential for improved patient compliance and satisfaction.
    • This delivery method offers an attractive alternative for hormone therapy, particularly for specific patient groups.